Bristol Myers Squibb, bluebird bio announce submission of BLA for Myeloma Drug to USFDA Medical Dialogues Bureau4 April 2020 8:39 AM GMTBCMA is a protein that is nearly universally expressed on cancer cells in multiple myeloma, making it an important potential target for the treatment...